Kala Pharmaceuticals to Present at the Canaccord Genuity Annual Growth Conference
8/8/2013 7:55:32 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Guillaume Pfefer, Ph.D., Kala’s Chief Executive Officer, is scheduled to present at the Canaccord Genuity Annual Growth Conference. The presentation will take place in Boston on Wednesday, August 14, 2013 at 9:30 a.m. ET.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by